m6A RNA modifications: Key regulators of normal and malignant hematopoiesis. (2022)

First Author: Sommerkamp P
Attributed to:  Therapeutic targeting of HIF prolyl hydroxylases in acute myeloid leukaemia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.exphem.2022.04.006

PubMed Identifier: 35487293

Publication URI: http://europepmc.org/abstract/MED/35487293

Type: Journal Article/Review

Volume: 111

Parent Publication: Experimental hematology

ISSN: 0301-472X